Rheumatoid arthritis: RA--lowering cardiovascular risk with statins.

Rheumatoid arthritis: RA--lowering cardiovascular risk with statins.

Show other versions (1)

Bibliographic Details
Main Authors:	Lee, J, Choudhury, R
Format:	Journal article
Language:	English
Published:	2010

Similar Items

Rheumatoid arthritis: RA-lowering cardiovascular risk with statins
by: Lee, J, et al.
Published: (2010)

RHEUMATOID ARTHRITIS AND CARDIOVASCULAR RISK: PERSPECTIVES OF TREATMENT WITH STATINS
by: D. A. Anichkov, et al.
Published: (2015-12-01)

RHEUMATOID ARTHRITIS AND CARDIOVASCULAR RISK: PERSPECTIVES OF TREATMENT WITH STATINS
by: D. A. Anichkov, et al.
Published: (2015-12-01)

The Role of Statins in Disease Modification and Cardiovascular Risk in Rheumatoid Arthritis
by: Stergios Soulaidopoulos, et al.
Published: (2018-02-01)

Reduction of cardiovascular risk in rheumatoid arthritis: double benefit of statins
by: Diana Sergeevna Novikova, et al.
Published: (2010-12-01)

Bone turnover in early rheumatoid arthritis (RA)
by: Sambrook, P, et al.
Published: (1985)

T cell genetics and rheumatoid arthritis (RA)
by: Wordsworth, P
Published: (1998)

JAK ACADEMY in Rheumatoid Arthritis (RA)
by: Roberto Caporali, et al.
Published: (2018-09-01)

MicroRNAs (miRNAs) in Cardiovascular Complications of Rheumatoid Arthritis (RA): What Is New?
by: Daniela Maria Tanase, et al.
Published: (2022-05-01)

METHOTREXATE AND CARDIOVASCULAR RISK IN RHEUMATOID ARTHRITIS
by: Tatiana Valentinovna Popkova, et al.
Published: (2012-12-01)

Cardiovascular risk in patients with rheumatoid arthritis
by: N M Nikitina, et al.
Published: (2009-06-01)

Risk of rheumatoid arthritis diagnosis in statin users in a large nationwide US study
by: Madeline N. Peterson, et al.
Published: (2021-09-01)

Adenosine Deaminase (ADA) in Rheumatoid Arthritis in patients (RA)
by: Huda Th. Al-Marsomi
Published: (2009-07-01)

Biologics in rheumatoid arthritis (RA) – recommendations for Swiss practice
by: BA Michel
Published: (2011-05-01)

Immune, metabolism and therapeutic targets in RA (Rheumatoid Arthritis)
by: Liu Keying
Published: (2022-01-01)

IL-1Ra: its role in rheumatoid arthritis
by: M. Cutolo
Published: (2011-09-01)

Management of Cardiovascular Disease Risk in Rheumatoid Arthritis
by: Patrick H. Dessein, et al.
Published: (2022-06-01)

Patient Perception of Cardiovascular Risk in Rheumatoid Arthritis
by: Shubhasree Banerjee, et al.
Published: (2020-05-01)

Risk of cardiovascular disease in rheumatoid arthritis patients
by: A P Utari, et al.
Published: (2018-02-01)

Cardiovascular Risk in Rheumatoid Arthritis: Literature Review
by: Suad MA Hannawi, et al.
Published: (2021-05-01)

Cardiovascular Risk in Rheumatoid Arthritis: Literature Review
by: Suad MA Hannawi, et al.
Published: (2021-05-01)

Risk factors of cardiovascular diseases in rheumatoid arthritis
by: T V Popkova, et al.
Published: (2009-06-01)

Renal function and cardiovascular risk in rheumatoid arthritis
by: N. A. Khramtsova, et al.
Published: (2010-10-01)

Abatacept and cardiovascular risk in rheumatoid arthritis: update
by: T. V. Popkova
Published: (2018-01-01)

Cardiovascular risk factors in psoriatic and rheumatoid arthritis
by: Andrey Petrovich Rebrov, et al.
Published: (2011-05-01)

The Expanded Risk Score in Rheumatoid Arthritis (ERS-RA): performance of a disease-specific calculator in comparison with the traditional prediction scores in the assessment of the 10-year risk of cardiovascular disease in patients with rheumatoid arthritis
by: Fausto Salaffi, et al.
Published: (2018-08-01)

Cardiovascular risk in persons at risk of developing rheumatoid arthritis.
by: Laurette van Boheemen, et al.
Published: (2020-01-01)

Concomitant use of statins in filgotinib-treated patients with rheumatoid arthritis
by: Taylor, PC, et al.
Published: (2021)

Interleukin 10 (IL-10) haplotypes are associated with rheumatoid arthritis (RA).
by: MacKay, K, et al.
Published: (2000)

Statin indication according to the 2019 World Health Organization cardiovascular disease risk charts and carotid ultrasound in Mexican mestizo rheumatoid arthritis patients
by: Dionicio A. Galarza-Delgado, et al.
Published: (2022-01-01)

The role of IL-10 in rheumatoid arthritis (RA) in two ethnically diverse populations.
by: MacKay, K, et al.
Published: (1999)

Choosing lipid lowering statin in risk strategy of cardiovascular event prevention
by: A. Ya. Yvleva, et al.
Published: (2007-02-01)

Cardiovascular Disease Risk in Rheumatoid Arthritis Anno 2022
by: Bas Dijkshoorn, et al.
Published: (2022-05-01)

EVALUATION OF CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: I. A. Starodubtseva, et al.
Published: (2016-02-01)

Cardiovascular risk in rheumatoid arthritis: a narrative review
by: Manuel Felipe Cáceres Acosta, et al.
Published: (2017-09-01)

СLINICAL EFFICIENCY OF STATINS IN RHEUMATOID ARTHRITIS: A PILOT STUDY
by: I. V. Shirinsky, et al.
Published: (2014-07-01)

Protocol for the pilot randomized trial of the CArdiovascular Risk assEssment for Rheumatoid Arthritis (CARE RA) intervention: a peer coach behavioral intervention
by: Joan Weiner, et al.
Published: (2022-04-01)

Rheumatoid arthritis and cardiovascular pathology
by: Saule Abisheva, et al.
Published: (2018-04-01)

Cardiovascular disease risk evaluation impact in patients with rheumatoid arthritis
by: Avi Aronov, et al.
Published: (2022-12-01)

A survey of a footwear service for people with Rheumatoid Arthritis (RA)
by: Field Robert
Published: (2010-12-01)